Regular update of the Norwegian Laboratory Code System released

26

May 2023

In late May 2023, the Norwegian Directorate of e-Health released an updated version of the Norwegian Laboratory Code (NLK) system to be implemented no later than July 1, 2023. The document with the allocation of new codes to reimbursement categories is not yet available. NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.

A total of 142 new codes were added to NLK in medical biochemistry, clinical pharmacology, and medical microbiology fields. Some examples of the newly-added codes are:

  • NPU19053 DNA CYP21A2 gene;
  • NPU62051 Sp-Cytomegalovirus (CMV) IgG production (spinal fluid);
  • NPU58983 Us-Haemophilus influenza DNA (unspecified);
  • NPU62030 B-Yersinia pestis DNA (blood);
  • NPU62020 B-West Nile virus RNA (blood);
  • NPU62021 B-Yellow fever virus RNA (blood);
  • NPU62036 P-Broad substance search (plasma).

Furthermore, 33 codes were terminated, and 122 codes were amended

See more information in Norwegian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

06

Jun 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2023. Twenty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, gastrointestinal, and orthopedic devices, as well as medical aids.

Read more

01

Jun 2023

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

Read more

31

May 2023

In May 2023, the government revised the national budget and proposed changes in the central health administration's roles, organization, and responsibilities to be implemented on January 1, 2024. The reorganization includes the merger of the Directorate of Health and the Directorate of e-Health.

Read more

29

May 2023

On May 17, 2023, the Ministry of Health and Prevention published the 2023-2027 Digital Health Roadmap. The new roadmap specifies the priorities and the projects to be carried out by 2027. One of the key objectives is to support the implementation and extension of telemonitoring to more chronic pathologies.

Read more

25

May 2023

On May 17, 2023, NHS England issued an updated version of the National Genomic Test Directory for cancer, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Two new codes (test-indication combinations) were introduced.

Read more